Скачать презентацию Acute Renal Replacement Therapy for the Infant Dr Скачать презентацию Acute Renal Replacement Therapy for the Infant Dr

4395cb6f4f80279cf4221c9bee92b617.ppt

  • Количество слайдов: 34

Acute Renal Replacement Therapy for the Infant Dr. Fahad Gadi, MD Pediatrics Demonstrator King Acute Renal Replacement Therapy for the Infant Dr. Fahad Gadi, MD Pediatrics Demonstrator King Abdulaziz University Rabigh Medical School

Objectives • Indications and goals for acute renal replacement therapy • Modalities for renal Objectives • Indications and goals for acute renal replacement therapy • Modalities for renal replacement therapy – Peritoneal dialysis – Intermittent hemodialysis – Continuous renal replacement therapy (CRRT) • Special issues related to the infant

Indications for Renal Replacement • • Volume overload Metabolic imbalance Toxins (endogenous or exogenous) Indications for Renal Replacement • • Volume overload Metabolic imbalance Toxins (endogenous or exogenous) Inability to provide needed daily fluids due to insufficient urinary excretion

Goals of Renal Replacement • Restore fluid, electrolyte and metabolic balance • Remove endogenous Goals of Renal Replacement • Restore fluid, electrolyte and metabolic balance • Remove endogenous or exogenous toxins as rapidly as possible • Permit needed therapy and nutrition • Limit complications

Renal Replacement for the Infant: A Set of Special Challenges • Small size of Renal Replacement for the Infant: A Set of Special Challenges • Small size of the patient • Equipment designed for larger people • Small blood volume will magnify effects of any errors • Achieving access may be difficult • Staff may have infrequent experience

Modalities for Renal Replacement • Peritoneal dialysis • Intermittent hemodialysis • Continuous renal replacement Modalities for Renal Replacement • Peritoneal dialysis • Intermittent hemodialysis • Continuous renal replacement therapy (CRRT)

Modalities for Renal Replacement • Peritoneal dialysis • Intermittent hemodialysis • Continuous renal replacement Modalities for Renal Replacement • Peritoneal dialysis • Intermittent hemodialysis • Continuous renal replacement therapy (CRRT)

PD: Considerations for Infants • • • ADVANTAGES Experience in the chronic setting No PD: Considerations for Infants • • • ADVANTAGES Experience in the chronic setting No vascular access No extracorporeal perfusion Simplicity ? Preferred modality for cardiac patients? • • • DISADVANTAGES Infectious risk Leak ? Respiratory compromise? Sodium sieving Dead space in tubing

Sodium Sieving: A Problem of Short Dwell PD Na+ H 2 O Na+ H Sodium Sieving: A Problem of Short Dwell PD Na+ H 2 O Na+ H 2 O Na+ Result: Hypernatremia Na+ H 2 O H 2 O Na+

Dead Space: A Problem with Low Volume PD Dead Space: A Problem with Low Volume PD

Modalities for Renal Replacement • Peritoneal dialysis • Intermittent hemodialysis • Continuous renal replacement Modalities for Renal Replacement • Peritoneal dialysis • Intermittent hemodialysis • Continuous renal replacement therapy (CRRT)

IHD: Considerations for Infants ADVANTAGES • Rapid particle and fluid removal; most efficient modality IHD: Considerations for Infants ADVANTAGES • Rapid particle and fluid removal; most efficient modality • Does not require anticoagulation 24 h/d • • • DISADVANTAGES Vascular access Complicated Large extracorporeal volume Adapted equipment ? Poorly tolerated

Modalities for Renal Replacement • Peritoneal dialysis • Intermittent hemodialysis • Continuous renal replacement Modalities for Renal Replacement • Peritoneal dialysis • Intermittent hemodialysis • Continuous renal replacement therapy (CRRT)

Pediatric CRRT: Vicenza, 1984 Pediatric CRRT: Vicenza, 1984

CRRT for Infants: A Series of Challenges • • • Small patient with small CRRT for Infants: A Series of Challenges • • • Small patient with small blood volume Equipment designed for bigger people No specific protocols Complications may be magnified No clear guidelines Limited outcome data

Potential Complications of Infant CRRT • • • Volume related problems Biochemical and nutritional Potential Complications of Infant CRRT • • • Volume related problems Biochemical and nutritional problems Hemorrhage, infection Thermic loss Technical problems Logistical problems

CRRT in Infants <10 Kg: Outcome 38% Survival 41% Survival 25% Survival Patients <10 CRRT in Infants <10 Kg: Outcome 38% Survival 41% Survival 25% Survival Patients <10 kg Patients 3 -10 kg Am J Kid Dis, 18: 833 -837, 2003 Patients <3 kg

pp. CRRT Data of Infants <10 Kg: Demographic Information Number of Subjects 84 (51 pp. CRRT Data of Infants <10 Kg: Demographic Information Number of Subjects 84 (51 boys (61%)) (33 girls (39%)) Age Median 69 days (1 d - 2. 9 y) ICU Admit weight Median 4. 4 kg (1. 3 - 10 kg)

pp. CRRT Data of Infants <10 Kg: Primary Diagnoses pp. CRRT Data of Infants <10 Kg: Primary Diagnoses

pp. CRRT Data of Infants <10 Kg: Indications for CRRT Fluid Overload and Electrolyte pp. CRRT Data of Infants <10 Kg: Indications for CRRT Fluid Overload and Electrolyte Imbalance 84% Other (Endogenous Toxin Removal) 16% N=84

pp. CRRT Data of Infants <10 Kg: Clinical Data Parameter Days in ICU prior pp. CRRT Data of Infants <10 Kg: Clinical Data Parameter Days in ICU prior to CRRT PRISM score — ICU admit PRISM score — CRRT start Inotrope number — CRRT start Urine output — CRRT start (ml/kg/hr over prior 24 hrs) % Fluid overload from ICU admission to CRRT start Median Range 2 0 - 135 17. 5 0 - 48 20 0 - 48 1 0 -4 0. 7 0 - 12 13. 7 -28 - 220

pp. CRRT Data of Infants <10 Kg: Technical Characteristics of CRRT Catheter Site Modality pp. CRRT Data of Infants <10 Kg: Technical Characteristics of CRRT Catheter Site Modality N=84 Femoral Internal Jugular Subclavian CVVHDF Anticoagulation Citrate Heparin Prime Blood Saline Albumin 60% 28% 12% 59% 18% 23% 55% 45% 87% 8% 5%

pp. CRRT Data of Infants <10 Kg: CRRT Treatment Data Parameter Blood Flow (ml/kg/min) pp. CRRT Data of Infants <10 Kg: CRRT Treatment Data Parameter Blood Flow (ml/kg/min) Fluid Flow (ml/kg/hour) Average CRRT Clearance (ml/hr/1. 73 M 2) Aggregate CRRT Clearance (ml/hr/1. 73 M 2) CRRT duration (days) N=84 Median Range 8 1. 7 -46 67 7 -571 2582 135 -19319 3540 5 135 -12713 0 -83

pp. CRRT Data of Infants <10 Kg: Survival by Weight p=0. 001 p=1. 0 pp. CRRT Data of Infants <10 Kg: Survival by Weight p=0. 001 p=1. 0 44% 42% 43% 64%

pp. CRRT Data of Infants <10 Kg: Factors Effecting Survival Clinical Variable Admission PRISM pp. CRRT Data of Infants <10 Kg: Factors Effecting Survival Clinical Variable Admission PRISM score GI/Hepatic disease Multiorgan dysfunction Pressor Dependency Mean Airway Pressure Initial urine output (ml/kg/hr) %Fluid Overload at Start >10% Overload at Start Survivors Non-Survivors P 16 21 <0. 05 8% 31% 0. 01 68% 91% 0. 04 36% 11 2. 4 15% 43% 69% 20 1. 0 34% 71% <0. 01 <0. 001 0. 02

pp. CRRT Data of Infants <10 Kg: Survival by Return to Dry Weight 78% pp. CRRT Data of Infants <10 Kg: Survival by Return to Dry Weight 78% 65% 35% 22%

PRISMA • Dedicated CRRT device • Highly automated • Designed for ease of use PRISMA • Dedicated CRRT device • Highly automated • Designed for ease of use at the bedside

Bradykinin Release Syndrome • Mucosal congestion, bronchospasm, hypotension at start of CRRT • Resolves Bradykinin Release Syndrome • Mucosal congestion, bronchospasm, hypotension at start of CRRT • Resolves with discontinuation of CRRT • Thought to be related to bradykinin release when patient’s blood contacts hemofilter • Exquisitely p. H sensitive

Bypass System to Prevent Bradykinin Release Syndrome PRBC Waste Bypass System to Prevent Bradykinin Release Syndrome PRBC Waste

Recirculation System to Prevent Bradykinin Release Syndrome Normalize p. H Recirculation Plan: D Qb Recirculation System to Prevent Bradykinin Release Syndrome Normalize p. H Recirculation Plan: D Qb 200 ml/min Qd ~40 ml/min Time 7. 5 min Normalize K+ Waste

Acute Initiation Checklist: Example Infant ICU Nurse • Time Zero: – Move pt to Acute Initiation Checklist: Example Infant ICU Nurse • Time Zero: – Move pt to room with dialysis water – Get orders from resident for IV fluids to keep access open • 20 – 40 min: – Meet MD; discuss RRT plan • 60 – 120 min: – Meet ICU team Dialysis Nurse • 10 – 60 min: – Arrive and begin setup • 20 – 40 min: – Meet MD; discuss RRT plan • 60 – 120 min: – Complete prime; ready for access – Begin RRT – Meet ICU team

Acute Initiation Checklist: Example Nephrology MD • Time Zero: – Contact dialysis nurse to Acute Initiation Checklist: Example Nephrology MD • Time Zero: – Contact dialysis nurse to start RRT urgently • 10 – 20 min: – Bring catheters to ICU – Enter orders for RRT • 20 – 40 min: – Meet ICU MDs & RNs, discuss plan • 60 – 120 min: – Present in ICU for initiation – Meet ICU team IV Access MD • 10 – 30 min: – Arrive and begin insertion of dialysis access • 60 min (or when circuit is ready for Rx) – Complete insertion of access – Connect ports to heparin IV solutions

Infant RRT: Summary • • All modalities of RRT possible for infants No modality Infant RRT: Summary • • All modalities of RRT possible for infants No modality is perfect Technical challenges can be met Careful planning with institution, program, and individuals improves care • Cooperation, communication, and collaboration will increase our success

Thanks! Thanks!